BANVT.E — Banvit Bandirma Vitaminli Yem Sanayi AS Balance Sheet
0.000.00%
- TRY15.00bn
- TRY12.57bn
- TRY33.49bn
Annual balance sheet for Banvit Bandirma Vitaminli Yem Sanayi AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
R2021 December 31st | R2022 December 31st | R2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 753 | 815 | 1,727 | 6,866 | 6,967 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 570 | 1,448 | 2,565 | 3,260 | 2,999 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,015 | 7,051 | 9,321 | 16,555 | 16,477 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 755 | 4,625 | 6,318 | 8,008 | 8,681 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,812 | 12,200 | 15,782 | 24,620 | 25,185 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,164 | 7,047 | 8,152 | 10,166 | 12,548 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2,568 | 8,198 | 9,428 | 11,526 | 14,114 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,244 | 4,001 | 6,355 | 13,095 | 11,071 |
| Total Liabilities & Shareholders' Equity | 3,812 | 12,200 | 15,782 | 24,620 | 25,185 |
| Total Common Shares Outstanding |